Condition in which a woman without diabetes develops high blood sugar levels during pregnancy.
Spacecraft docking system.
1Main outcome measure: The development of a clinical prediction rule for GDM.
2GDM may be involved in the foetal programming of long-term cardiovascular health.
3Study design: Secondary analysis of a multicenter treatment trial of mild GDM.
4Therefore we compared SAF at diagnosis in GDM patients with normal pregnancy.
5Patients underwent CGM within 3 weeks of receiving a diagnosis of GDM.
6Short stature and smoking in pregnancy were additional risk factors for GDM.
7Studies whose subjects were diagnosed with GDM prior to intervention were excluded.
8Maternal characteristics and medical history were investigated to evaluate associations with GDM.
9Population: Nine hundred and ninety-five consecutive pregnant women underwent screening for GDM.
10GDm-Health is a patient-to-clinician system for the management of diabetes in pregnancy.
11Studies that compared women diagnosed with GDM and healthy controls were included.
12Our findings also emphasize the heterogeneity of factors which predispose to GDM.
13A later diagnosis of GDM is more prevalent in presumed low-risk pregnancies.
14The miR-181a was down-regulated only in umbilical-cord blood cells of GDM neonates.
15Further research could aim to report data for standardised GDM outcomes.
16Conclusions: An elevated NLR level is a powerful and independent predictor of GDM.